Clinical Trial Update: Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures [Phase 3]

View source ↗

Summary

Phase 3 trial investigating eltrombopag to reduce platelet transfusions in patients with chronic liver disease and thrombocytopenia undergoing invasive procedur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Non-alcoholic Steatohepatitis
• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Non-alcoholic Steatohepatitis, Chronic Liver Disease | Phase 3 | Status: TERMINATED | Results posted: 2010-11-08